Your session is about to expire
← Back to Search
Polyphenol Supplement
Whole coffee cherry extract for Drug Effects (WCCE Trial)
N/A
Waitlist Available
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily for the duration of the study (approximately 28 days)
Awards & highlights
WCCE Trial Summary
This trial will study the effects of a coffee cherry extract on measures of cognition.
WCCE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ daily for the duration of the study (approximately 28 days)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily for the duration of the study (approximately 28 days)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Behavioral Measures - Change in Face in the Crowd Time
Behavioral Measures - Change in Face-Name Reaction Time
Behavioral Measures - Change in Flanker Task Reaction Time
+5 moreSecondary outcome measures
Daily Self-reported Mood
Daily Self-reported Sleep
Weekly Self-reported Mood
+1 moreOther outcome measures
Compliance
WCCE Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Whole coffee cherry extractActive Control1 Intervention
Whole coffee cherry extract (WCCE; otherwise known as the generally-recognized-as-safe (GRAS) supplement Neurofactor(TM)), is a proprietary, safe, powdered extract of whole coffee cherries from coffea arabica with high levels of polyphenols and substantially low (<2%; <4mg) levels of caffeine. The only content of the supplement is WCCE - there are no excipients, binders, or flow agents, nor are there any other materials. The coffee cherry is subjected to a food-grade water ethanol extraction; thus, after extraction, only 100% coffee-based components remain. 200mg of WCCE will be administered daily for 28 days.
Group II: PlaceboPlacebo Group1 Intervention
The placebo will be a simple microcellulose, which is generally-recognized-as-safe (GRAS) and commonly used in food products.
Find a Location
Who is running the clinical trial?
VDF FutureCeuticals Inc.Industry Sponsor
4 Previous Clinical Trials
117 Total Patients Enrolled
Auburn UniversityLead Sponsor
72 Previous Clinical Trials
14,080 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a health condition, like Parkinson's or ADHD, that may make it difficult for you to fully participate in the study.You are currently taking medications like insulin or metformin that affect your body's metabolism.You are currently taking medications that may affect your thinking abilities, like medications for mood or anxiety.You have used CBD or multivitamins within the past two weeks.You do not have any known mental or brain disorders.You have certain health conditions that affect your metabolism.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo
- Group 2: Whole coffee cherry extract
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger